Swedish Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Orexo

Market Cap: SEK 680.4m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Aptahem

Market Cap: SEK 20.1m

A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.

LIDDS

Market Cap: SEK 6.8m

A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.

Medivir

Market Cap: SEK 182.8m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.

Elicera Therapeutics

Market Cap: SEK 259.7m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Abera Bioscience

Market Cap: SEK 125.9m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Respiratorius

Market Cap: SEK 45.0m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Modus Therapeutics Holding

Market Cap: SEK 46.0m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

AcouSort

Market Cap: SEK 71.7m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

Kancera

Market Cap: SEK 226.9m

Develops drugs for inflammatory diseases and cancer in Sweden and internationally.

PEPTONIC medical

Market Cap: SEK 92.1m

A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.

Magnasense

Market Cap: SEK 8.7m

Develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs.

Vitrolife

Market Cap: SEK 18.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 63.3m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, as well as opioid overdose and anaphylactic shock.

Eevia Health Oyj

Market Cap: SEK 7.2m

Produces and distributes organic bioactive plant extracts in Finland and internationally.

Flerie

Market Cap: SEK 3.6b

A venture capital firm specializing in early-stage investments.

Alligator Bioscience

Market Cap: SEK 155.9m

A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Finland and Sweden.

Stayble Therapeutics

Market Cap: SEK 29.9m

Develops injectable treatment for chronic pain triggered by disc degeneration.

Dextech Medical

Market Cap: SEK 147.9m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Magle Chemoswed Holding

Market Cap: SEK 570.3m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

IDL Diagnostics

Market Cap: SEK 119.8m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Spermosens

Market Cap: SEK 10.8m

Provides diagnostic health care products and services in Sweden.

SenzaGen

Market Cap: SEK 149.9m

Provides non-animal tests for assessing allergenicity.

Genovis AB (publ.)

Market Cap: SEK 1.8b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Pila Pharma

Market Cap: SEK 93.5m

Operates as a clinical stage biotech company in Sweden.

Spago Nanomedical

Market Cap: SEK 93.0m

A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.

Xbrane Biopharma

Market Cap: SEK 361.9m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

NextCell Pharma

Market Cap: SEK 111.1m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

Cessatech

Market Cap: DKK 206.0m

A pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark.

BioInvent International

Market Cap: SEK 2.4b

A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Prostatype Genomics

Market Cap: SEK 48.9m

Prostatype Genomics AB manufactures, markets, and sells prognostic gene tests.

Gabather

Market Cap: SEK 11.1m

A pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases.

Active Biotech

Market Cap: SEK 237.7m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Egetis Therapeutics

Market Cap: SEK 1.5b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Promimic

Market Cap: SEK 348.6m

Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.

Enzymatica

Market Cap: SEK 682.1m

A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.